Family Medicine · San Antonio, TX
NPI
1427252089
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
720 Pleasanton Rd
San Antonio, TX, 78214
Phone (210) 921-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
885 services
Medicare patients, 2024
123
Average age 76
Drug cost, 2024
$3.4M
22,165 prescriptions
Company payments, 2025
$1,896
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jesus G Garcia-Gallegos was code 99214 (office e&m - established), 169 times for 91 patients. In total Jesus G Garcia-Gallegos billed 885 services in 63 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 169 | 91 | $75.43 | $13K |
| 82962 Clinical Chemistry | Office | 118 | 75 | $3.13 | $370 |
| 96372 Injection Administration | Office | 70 | 33 | $10.18 | $712 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 51 | 25 | $0.89 | $45.47 |
| 99215 Office E&M - Established | Office | 50 | 30 | $134.42 | $6,721 |
| 71046 X-ray - Chest | Office | 32 | 27 | $17.62 | $564 |
| G0008 Administration of influenza virus vaccine | Office | 20 | 19 | $31.03 | $621 |
| 99211 Office E&M - Established | Office | 16 | 11 | $16.41 | $263 |
| 90662 Vaccine Product | Office | 13 | 12 | $80.30 | $1,044 |
| 93000 Electrocardiogram | Office | 12 | 12 | $9.91 | $119 |
By year: 2022 $37K for 1,001 services; 2023 $35K for 941 services; 2024 $29K for 885 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 118 | 75 | $3.13 | $370 |
Medicare prescription drug claims, 2024
In 2024, the drug Jesus G Garcia-Gallegos prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,291 prescriptions and refills. In total Jesus G Garcia-Gallegos wrote 22,165 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,291 | 3,851 | 432 | $12K |
| Lisinopril Generic | 1,078 | 3,230 | 323 | $8,090 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 1,048 | 2,924 | 422 | $14K |
| Levothyroxine Sodium Generic | 960 | 2,791 | 282 | $8,013 |
| Amlodipine Besylate Generic | 773 | 2,293 | 261 | $5,219 |
| Losartan Potassium Generic | 727 | 2,203 | 244 | $6,127 |
| Rosuvastatin Calcium Generic | 632 | 1,911 | 205 | $8,858 |
| Gabapentin Generic | 573 | 918 | 198 | $9,005 |
| Pioglitazone Hcl Generic | 531 | 1,572 | 208 | $6,137 |
| Omeprazole Generic | 520 | 1,397 | 180 | $13K |
| Metformin Hcl Generic | 492 | 1,456 | 160 | $4,335 |
| Ozempic Semaglutide | 490 | 633 | 116 | $624K |
| Montelukast Sodium Generic | 463 | 1,299 | 192 | $6,059 |
| Tizanidine Hcl Generic | 440 | 582 | 201 | $5,533 |
| Mounjaro Tirzepatide | 392 | 425 | 65 | $454K |
Brand drugs: 3,538 claims; generic drugs: 18,382 claims; opioid claims: 251.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jesus G Garcia-Gallegos $1,896 ($1,896 in general payments such as food, travel and fees) from 14 companies. The largest payer was Lilly USA, LLC with $355.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 8 | $355 |
| Dexcom, Inc. DXCM | 18 | $311 |
| Abbvie Inc. ABBV | 20 | $294 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $208 |
| Sumitomo Pharma America, Inc. 4506.T | 10 | $183 |
| Novo Nordisk Inc NVO | 9 | $154 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $107 |
| Lundbeck LLC | 3 | $63.94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $56.61 |
| Abbott Laboratories ABT | 2 | $47.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.